Survey of pediatric transplant center practices regarding COVID-19 vaccine mandates for transplant candidates and living donors and use of COVID-19-positive deceased organs.


Journal

Pediatric transplantation
ISSN: 1399-3046
Titre abrégé: Pediatr Transplant
Pays: Denmark
ID NLM: 9802574

Informations de publication

Date de publication:
09 2023
Historique:
revised: 27 09 2022
received: 10 08 2022
accepted: 28 11 2022
medline: 28 8 2023
pubmed: 21 3 2023
entrez: 20 3 2023
Statut: ppublish

Résumé

COVID-19 vaccine is recommended for individuals ages ≥6 months; however, whether vaccination should be mandated for transplant candidates and living donors remains controversial. This study assessed COVID-19 policies at US pediatric solid organ transplant centers. A 79-item survey was emailed between March and April 2022 to 200 UNOS Medical Directors detailing center COVID-19 vaccine policies for transplant candidates and living donors and use of grafts from COVID-19-positive deceased donors. The response rate was 77% (154/200). For children aged 5-15 years, 23% (35/154 centers) have a COVID-19 vaccine mandate, 27% (42/154) anticipate implementing a future mandate, and 47% (72/154) have not considered or do not anticipate implementing a mandate. For children ≥16 years, 32% (50/154 centers) have a COVID-19 vaccine mandate, 25% (39/154) anticipate implementing a future mandate, and 40% (62/154) have not considered or do not anticipate implementing a mandate. The top two reasons for not implementing a COVID-19 vaccine mandate were concerns about penalizing a child for their parent's decision and worsening inequities in transplant. Of 85 kidney and liver living donor centers, 32% (27/85) require vaccination of donors. Twenty percent (31/154) of centers accept organs from COVID-19-positive deceased donors. There is great variation among pediatric SOT centers in both the implementation and details of COVID-19 vaccine mandates for candidates and living donors. To guide more uniform policies, further data are needed on COVID-19 disease, vaccine efficacy, and use of grafts from donors positive for COVID-19 in the pediatric transplant population.

Sections du résumé

BACKGROUND
COVID-19 vaccine is recommended for individuals ages ≥6 months; however, whether vaccination should be mandated for transplant candidates and living donors remains controversial. This study assessed COVID-19 policies at US pediatric solid organ transplant centers.
METHODS
A 79-item survey was emailed between March and April 2022 to 200 UNOS Medical Directors detailing center COVID-19 vaccine policies for transplant candidates and living donors and use of grafts from COVID-19-positive deceased donors.
RESULTS
The response rate was 77% (154/200). For children aged 5-15 years, 23% (35/154 centers) have a COVID-19 vaccine mandate, 27% (42/154) anticipate implementing a future mandate, and 47% (72/154) have not considered or do not anticipate implementing a mandate. For children ≥16 years, 32% (50/154 centers) have a COVID-19 vaccine mandate, 25% (39/154) anticipate implementing a future mandate, and 40% (62/154) have not considered or do not anticipate implementing a mandate. The top two reasons for not implementing a COVID-19 vaccine mandate were concerns about penalizing a child for their parent's decision and worsening inequities in transplant. Of 85 kidney and liver living donor centers, 32% (27/85) require vaccination of donors. Twenty percent (31/154) of centers accept organs from COVID-19-positive deceased donors.
CONCLUSIONS
There is great variation among pediatric SOT centers in both the implementation and details of COVID-19 vaccine mandates for candidates and living donors. To guide more uniform policies, further data are needed on COVID-19 disease, vaccine efficacy, and use of grafts from donors positive for COVID-19 in the pediatric transplant population.

Identifiants

pubmed: 36939212
doi: 10.1111/petr.14513
pmc: PMC10509306
mid: NIHMS1892449
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14513

Subventions

Organisme : AHRQ HHS
ID : K08 HS026510
Pays : United States
Organisme : AHRQ HHS
ID : K08 HS026510
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Pediatr Transplant. 2022 Aug;26(5):e14235
pubmed: 35060251
Front Pediatr. 2020 Dec 10;8:612627
pubmed: 33363069
Am J Transplant. 2021 Aug;21(8):2637-2645
pubmed: 33370501
MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):271-278
pubmed: 35176003
Transpl Infect Dis. 2017 Feb;19(1):
pubmed: 27862712
Transplantation. 2022 Apr 1;106(4):693-695
pubmed: 35238852
Am J Transplant. 2022 Feb;22(2):371-380
pubmed: 34706165
Am J Transplant. 2022 Feb;22(2):669-672
pubmed: 34517430
J Pediatr Gastroenterol Nutr. 2021 Jun 1;72(6):807-814
pubmed: 33605666
Pediatr Transplant. 2022 Mar;26(2):e14162
pubmed: 34633127
JAMA. 2021 Jun 1;325(21):2204-2206
pubmed: 33950155
MMWR Morb Mortal Wkly Rep. 2021 Sep 10;70(36):1249-1254
pubmed: 34499628
Am J Transplant. 2022 Oct;22(10):2481-2483
pubmed: 35510786
Vaccine. 2009 May 11;27(21):2812-5
pubmed: 19366583
JAMA. 2019 Nov 12;322(18):1822-1824
pubmed: 31714979
Curr Transplant Rep. 2022;9(2):95-107
pubmed: 35284204
Pediatr Transplant. 2013 May;17(3):244-50
pubmed: 23347536
Pediatr Transplant. 2022 Nov;26(7):e14243
pubmed: 35150196
J Pediatr Gastroenterol Nutr. 2022 Feb 1;74(2):e43-e44
pubmed: 34654794
N Engl J Med. 2021 Aug 12;385(7):661-662
pubmed: 34161700
J Heart Lung Transplant. 2022 Jan;41(1):17-19
pubmed: 34799246
MMWR Morb Mortal Wkly Rep. 2021 Sep 10;70(36):1255-1260
pubmed: 34499627
J Pediatric Infect Dis Soc. 2022 Feb 23;11(2):43-54
pubmed: 34734268
Semin Pediatr Surg. 2022 Jun;31(3):151178
pubmed: 35725046
Hepatology. 2001 Jul;34(1):28-31
pubmed: 11431730
Am J Transplant. 2022 Jun;22(6):1705-1713
pubmed: 35143100
Am J Transplant. 2020 Jul;20(7):1809-1818
pubmed: 32282982
Am J Transplant. 2020 Nov;20(11):3131-3139
pubmed: 32594606
Pediatr Res. 2008 Jul;64(1):100-4
pubmed: 18344901
Am J Transplant. 2022 Feb;22(2):381-385
pubmed: 34780109
JAMA Pediatr. 2019 Mar 1;173(3):260-268
pubmed: 30640369
Clin Transplant. 2021 Oct;35(10):e14421
pubmed: 34241923
Pediatr Nephrol. 2021 Jan;36(1):143-151
pubmed: 32980942
Transplantation. 2021 Jan 1;105(1):37-55
pubmed: 33148977
N Engl J Med. 2022 Jan 6;386(1):35-46
pubmed: 34752019
Liver Transpl. 2021 Dec;27(12):1852-1856
pubmed: 34407309
Am J Transplant. 2007 May;7(5):1209-14
pubmed: 17286615
JAMA Pediatr. 2018 Feb 1;172(2):111-112
pubmed: 29204650
Transplant Direct. 2021 Dec 23;8(1):e1268
pubmed: 34966840
J Pediatr Gastroenterol Nutr. 2022 Jan 1;74(1):159-170
pubmed: 34694269
Am J Transplant. 2021 Dec;21(12):3971-3979
pubmed: 34291552
Liver Transpl. 2022 Aug;28(8):1393-1396
pubmed: 35389558
J Pediatr. 2017 Mar;182:232-238.e1
pubmed: 28088400
Am J Transplant. 2021 May;21(5):1838-1847
pubmed: 33107180
Lancet Infect Dis. 2010 Aug;10(8):521-6
pubmed: 20620116

Auteurs

Amy G Feldman (AG)

Section of Pediatric Gastroenterology, Hepatology and Nutrition, Pediatric Liver Transplant Center, Digestive Health Institute, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.

Brenda Beaty (B)

Adult and Child Center for Outcomes Research and Delivery Science (ACCORDS), University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.

Melanie Everitt (M)

Pediatric Heart Transplant Program, Section of Pediatric Cardiology, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.

Jens Goebel (J)

Pediatrics and Human Development, Section of Pediatric Nephrology, Helen DeVos Children's Hospital, Michigan State University, Grand Rapids, Michigan, USA.

Allison Kempe (A)

Department of Pediatrics, Adult and Child Center for Outcomes Research and Delivery Science (ACCORDS), University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.

Lauren Pratscher (L)

Children's Hospital Colorado, Aurora, Colorado, USA.

Lara A Danziger-Isakov (LA)

Immunocompromised Host Infectious Disease, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH